The Primary Care Respiratory Society

Inspiring best practice in respiratory care

 Facebook LogoTwitter Logo

This website is for healthcare professionals only

FORD Meets FIRE Study Day

This has been produced by Focus on Integrated Respiratory Education (FIRE) and has been distributed by PCRS on their behalf. PCRS takes no responsibility for the content.

FORD Meets FIRE Study Day, Thursday 29th November, 0930-1600 hours, Napp Pharmaceuticals, Cambridge Science Park, CB4 0AB

The morning session is a general update for the generalist HCP and the afternoon is for more specialised respiratory HCPs. You are welcome to attend either or both sessions.

RSVP: to register your attendance please contact Val Gerrard (val.gerrard@nhs.net) stating AM/PM or both sessions.

0900-0930 hours    Coffee and registration
FORD Study Morning: Chair: TBC
0930-1030 hours    Setting the scene - political background to NHS care, local guidelines & initiatives Dr. Daryl Freeman
1030-1050 hours    Refreshments
1050-1200 hours    Decisions at step 2 focussing on the N&W guidelines / workshop interactive session Val Gerrard
1200-1230 hours    Device update - what’s new & inhaler device selection focussing on N&W guideline principles Mandy Beresford
1230-1330 hours    Lunch
 FIRE Study Afternoon: Chair: Sanjeev Rana
1230-1330 hours    Lunch
1330-1415 hours    Primary care Role in identification of patients with severe/uncontrolled asthma Dr. Daryl Freeman
1415-1430 hours    Refreshments
1430-1545 hours    Severe asthma - what happens when the patient is seen in secondary care clinic/ which mab for which patient? Dr. Nasser Shuaib
1545-1600 hours    Close

Meeting organised by Napp Pharmaceuticals Ltd, Dr Daryl Freeman, East of England PCRS representative and Val Gerrard FORD leader. The FIRE group is a PCRS affiliateed group.

There will be a separate area at this meeting with a promotional stand and materials.

Event Date: 
Thursday, 29th November 2018
Napp Pharmaceuticals Ltd
Contact Name: 
Val Gerrard
Event information
Commercial organisation produced
Clinical Area: 
Listing Status: